Advertisement

Anal Fistula pp 159-169 | Cite as

Tuberculosis Fistulas

Chapter

Abstract

The most frequently encountered anorectal tubercular lesions are suppurations and fistulae. A tubercular origin must be considered when the cause of fistula is unclear to avoid undesirable delay in the diagnosis and treatment of this disease. The epidemic of acquired immunodeficiency syndrome has caused a worldwide resurgence of tuberculosis. Positive diagnosis of anal tuberculosis depends on histological or bacteriologic analysis. The treatment is twofold: surgical for the suppuration as like any other cryptoglandular fistula with various surgical approaches and pharmacological treatment for tuberculosis. Once tuberculosis is confirmed, antitubercular treatment should be immediately started to ensure early healing and cure of the disease.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Tuberculin Skin Test Pulmonary Tuberculosis Anal Fistula 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Candela F, Serrano P, Arriero JM, Teruel A, Reyes D, Calpena R. Perianal disease of tuberculous origin: report of a case and review of the literature. Dis Colon Rectum. 1999;42:110–2.PubMedCrossRefGoogle Scholar
  2. 2.
    Harland RW, Varkey B. Anal tuberculosis: report of two cases and literature review. Am J Gastroenterol. 1992;87:1488–91.PubMedGoogle Scholar
  3. 3.
    Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol. 1993;88:989–99.PubMedGoogle Scholar
  4. 4.
    Archimandritis A, Kolitsopoulos A, Tzivras M, Fertakis A, Papalambrou E, Kittas C. Tuberculosis of the anal canal. J Clin Gastroenterol. 1993;16:89–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Shukla HS, Gupta SC, Singh G, Singh PA. Tubercular fistula in ano. Br J Surg. 1988;75:38–9.PubMedCrossRefGoogle Scholar
  6. 6.
    International Union Against Tuberculosis and Lung Disease. Tuberculosis: a guide to the essentials of good clinical practice. Paris: International Union Against Tuberculosis and Lung Disease; 2010.Google Scholar
  7. 7.
    Gupta PJ. Ano-perianal tuberculosis—solving a clinical dilemma. Afr Health Sci. 2005;5:345–7.PubMedGoogle Scholar
  8. 8.
    Aït-Khaled N, Alarcon E, Armengol R, Bissell K, Boillot F, Caminero JA. Management of tuberculosis: a guide to the essentials of good clinical practice. Paris: International Union Against Tuberculosis and Lung Disease; 2010.Google Scholar
  9. 9.
    Ottenhoff TH. Overcoming the global crisis: “yes, we can”, but also for TB … ? Eur J Immunol. 2009;39:2014–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Ducati RG, Rufinno-Netto A, Basso LA, Santos DS. The resumption of consumption: a review on tuberculosis. Mem Inst Oswaldo Cruz. 2006;01:697–714.Google Scholar
  11. 11.
    Romelaer C, Abramowitz L. Anal abscess with a tuberculous origin: report of two cases and review of the literature. Gastroenterol Clin Biol. 2007;31:94–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Myers SR. Tuberculous fissure-in ano. J R Soc Med. 1994;87:46.PubMedGoogle Scholar
  13. 13.
    Seghal VN, Jain MK, Srivastava G. Changing pattern of cutaneous tuberculosis: a prospective study. Int J Dermatol. 1989;28:231–6.CrossRefGoogle Scholar
  14. 14.
    Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Buie LA, Smith ND, Jackman RJ. The role of tuberculosis in anal fistula. Surg Gynecol Obstet. 1939;68:191–5.Google Scholar
  16. 16.
    Abcarian H. Anorectal infection: abscess-fistula. Clin Colon Rectal Surg. 2011;24:14–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Chung CC, Choi CL, Kwok SP, Leung KL, Lau WY, Li AK. Anal and perianal tuberculosis: a report of three cases in 10 years. J R Coll Surg Edinb. 1997;42:189–90.PubMedGoogle Scholar
  18. 18.
    Abdelwahab IF, Kenan S, Hermann G, Klein MJ. Tuberculous gluteal abscess without bone involvement. Skeletal Radiol. 1998;27:36–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Seow-Choen F, Hay AJ, Heard S, Philips RK. Bacteriology of anal fistula. Br J Surg. 1992;79:27–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Korman TM, Mijch AM, Bassily R, Grayson ML. Fistula in-ano: don’t forget tuberculosis. Med J Aust. 1996;166:387–8.Google Scholar
  21. 21.
    Rocha M, Carrasco C, Naquira N, Venegas J, Kauer G, Coñoman H. Anal tuberculosis: report of a case. Rev Med Chil. 1997;125:1199–203.PubMedGoogle Scholar
  22. 22.
    Gupta PJ. A case of multiple (eight external openings) tubercular anal fistulae: a case report. Eur Rev Med Pharmacol Sci. 2007;11:359–61.PubMedGoogle Scholar
  23. 23.
    Alvarez Conde JL, Gutierrez Alonso VM, Del Riego TJ, Garcia Martinez I, Arizcun Sanchez-Morate A, Vaquero PC. Perianal ulcers of tubercular origin. A report of 3 new cases. Rev Esp Enferm Dig. 1992;81:46–8.PubMedGoogle Scholar
  24. 24.
    Miteva L, Bardarov E. Perianal tuberculosis: a rare case of skin ulceration? Acta Derm Venereol. 2002;82:481–2.PubMedCrossRefGoogle Scholar
  25. 25.
    Aris EA, Bakari M, Chonde TM, Kitinya J, Swai AB. Diagnosis of tuberculosis in sputum-negative patients in Dar es Salaam. East Afr Med J. 1999;76:630–4.PubMedGoogle Scholar
  26. 26.
    Rose DN, Schechter CB, Adler JJ. Interpretation of the tuberculin skin test. J Gen Intern Med. 1995;10:635–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3:2–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Consensus Expert Committee API. API TB Consensus Guidelines 2006: management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. Assoc Phys India. 2006;54:219–34.Google Scholar
  29. 29.
    Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med. 2012;16:271–84.Google Scholar
  30. 30.
    Faizal M, Jimenez G, Burgos C, Portillo PD, Romero RE, Patarroya ME. Diagnosis of cutaneous tuberculosis by polymerase chain reaction using a species specific gene. Int J Dermatol. 1996;35:185–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigen. Am J Respir Crit Care Med. 2004;170:59–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Halligan S, Stoker J. Imaging of fistula in ano. Radiology. 2006;239:18–33.PubMedCrossRefGoogle Scholar
  33. 33.
    Gustafsson UM, Kahvecioglu B, Astrom G, Ahlstrom H, Graf W. Endoanal ultrasound or magnetic resonance imaging for preoperative assessment of anal fistula: a comparative study. Colorectal Dis. 2001;3:189–97.PubMedCrossRefGoogle Scholar
  34. 34.
    Lunniss PJ, Barker PG, Sultan AH, Armstrong P, Reznek RH, Bartram CI, et al. Magnetic resonance imaging of fistula-in-ano. Dis Colon Rectum. 1994;37:708–18.PubMedCrossRefGoogle Scholar
  35. 35.
    Gravante G, Giordano P. The role of three-dimensional endoluminal ultrasound imaging in the evaluation of anorectal diseases: a review. Surg Endosc. 2008;22:1570–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Maier AG, Funovics MA, Kreuzer SH, Herbst F, Wunderlich M, Teleky BK, et al. Evaluation of perianal sepsis: comparison of anal endosonography and magnetic resonance imaging. J Magn Reson Imaging. 2001;14:254–60.PubMedCrossRefGoogle Scholar
  37. 37.
    Schaefer O, Lohrmann C, Langer M. Assessment of anal fistulas with high resolution subtraction MR-fistulography: comparison with surgical findings. J Magn Reson Imaging. 2004;19:91–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Gan H, Ouyang Q, Bu H, et al. Value of polymerase chain reaction assay in diagnosis of intestinal tuberculosis and differentiation from Crohn’s disease. Chin Med J (Engl). 1994;107:215–20.Google Scholar
  39. 39.
    Portillo-Gomez L, Morris SL, Panduro A. Rapid and efficient detection of extra-pulmonary Mycobacterium tuberculosis by PCR analysis. Int J Tuberc Lung Dis. 2000;4:361–70.PubMedGoogle Scholar
  40. 40.
    Haldar S, Bose M, Chakrabarti P, Daginawala HF, Harinath BC, Kashyap RS, et al. Improved laboratory diagnosis of tuberculosis—the Indian experience. Tuberculosis. 2011;91:414–26.PubMedCrossRefGoogle Scholar
  41. 41.
    Parida SK, Kaufmann SH. The quest for biomarkers in tuberculosis. Drug Discov Today. 2010;15:148–57.PubMedCrossRefGoogle Scholar
  42. 42.
    Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn’s disease in populations with high- risk rates for tuberculosis. Aliment Pharmacol Ther. 2007;25:1373–88.PubMedCrossRefGoogle Scholar
  43. 43.
    Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, et al. Epidemiology and outcome of Crohns disease in a teaching hospital in Riyadh. World J Gastroenterol. 2004;10:1341–4.PubMedGoogle Scholar
  44. 44.
    Gupta PJ. Tubercular infection in the sacrococcygeal pilonidal sinus disease—a case report. Int Wound J. 2008;5:648–50.PubMedCrossRefGoogle Scholar
  45. 45.
    Schluger NW, Burzynski J. Tuberculosis and HIV infection: epidemiology, immunology, and treatment. HIV Clin Trials. 2001;2:356–65.PubMedCrossRefGoogle Scholar
  46. 46.
    Ghiya R, Sharma A, Marfatia YS. Perianal ulcer as a marker of tuberculosis in the HIV infected. Indian J Dermatol Venereol Leprol. 2008;74:386–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009–21.PubMedCrossRefGoogle Scholar
  48. 48.
    Lax JD, Haroutiounian G, Attia A, Rodriguez R, Thayaparan R, Bashist B. Tuberculosis of the rectum in a patient with acquired immune deficiency syndrome: report of a case. Dis Colon Rectum. 1988;31:394–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Barone B, Kreuzig PL, Gusmão PM, Chamié D, Bezerra S, Pinheiro P, et al. Case report of lymph nodal, hepatic and splenic tuberculosis in an HIV-positive patient. Braz J Infect Dis. 2006;10:149–53.PubMedCrossRefGoogle Scholar
  50. 50.
    Mehta JB, Dutt A, Harvill L, Mathews KM. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest. 1991;99:1134–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Garcia-Aguilar J, Belmonte C, Wong WD, Goldberg SM, Madoff RD. Anal fistula surgery. Factors associated with recurrence and incontinence. Dis Colon Rectum. 1996;39:723–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Malik AI, Nelson RL. Surgical management of anal fistulae: a systematic review. Colorectal Dis. 2008;10:420–30.PubMedCrossRefGoogle Scholar
  53. 53.
    Dudukgian H, Abcarian H. Why do we have so much trouble treating anal fistula? World J Gastroenterol. 2011;17:3292–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Blumetti J, Abcarian A, Quinteros F, Chaudhry V, Prasad L, Abcarian H. Evolution of treatment of fistula in ano. World J Surg. 2012;36:1162–7.PubMedCrossRefGoogle Scholar
  55. 55.
    WHO. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva, WHO; 2003. http://www.who.int/mediacentre/factsheets/fs104/en.
  56. 56.
    Peloquin CA. Pharmacological issues in the treatment of tuberculosis. Ann N Y Acad Sci. 2001;953:157–64.PubMedCrossRefGoogle Scholar
  57. 57.
    Heifets LB. Antimycobacterial drugs. Sem Respir Infect. 1994;9:84–103.Google Scholar
  58. 58.
    Israili ZH, Rogers CM, el-Attar H. Pharmacokinetics of antituberculosis drugs in patients. J Clin Pharmacol. 1987;27:78–83.PubMedCrossRefGoogle Scholar
  59. 59.
    Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Resp Res. 2001;2:164–8.CrossRefGoogle Scholar
  60. 60.
    World Health Organization. An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297. Geneva: WHO; 2002.Google Scholar
  61. 61.
    Burman WJ, Gallicano K, Peloquin C. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Clin Infect Dis. 1999;28:419–29.PubMedCrossRefGoogle Scholar
  62. 62.
    WHO. Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB 2003.313. Geneva: WHO; 2003.Google Scholar
  63. 63.
    Mitnick CD, McGee B, Peloquin CA. Tuberculosis pharmacotherapy: strategies to optimize patient care. Expert Opin Pharmacother. 2009;10:381–401.PubMedCrossRefGoogle Scholar
  64. 64.
    Ottenhoff THM, Kaufmann SHE. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 2012;8:e1002607.PubMedCrossRefGoogle Scholar
  65. 65.
    Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, et al. A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis. 2008;198:1491–501.PubMedCrossRefGoogle Scholar
  66. 66.
    Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine. 2007;25:14–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Kaufmann SH. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity. 2010;33:567–77.PubMedCrossRefGoogle Scholar
  68. 68.
    Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med. 2011;17:189–94.PubMedCrossRefGoogle Scholar
  69. 69.
    Lin PL, Dietrich J, Tan E, Abalos RM, Burgos J, et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest. 2012;122:303–14.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Fine Morning Hospital and Research Center, Gupta Nursing HomeNagpurIndia

Personalised recommendations